Buy Mirna Therapeutics Stock | MIRN Stock Price & Latest News | Public.com
MIRN

Mirna Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Mirna Therapeutics (MIRN) stock trends here

    About MIRN

    Synlogic, Inc. is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also work...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.3
    -0.44
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.42

    Actual EPS
    Q1 2021

    Stats

    Market Cap$140,72M
    Volume96,08k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.11
    1 Year Low$1.35
    Open$3.81
    High$3.90
    Low$3.62

    Buy any stock with any amount of money.

    Download the App
    Download the app